Your browser doesn't support javascript.
loading
Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials.
Eder, Lihi; Tony, Hans-Peter; Odhav, Satish; Agirregoikoa, Eva Galindez; Korkosz, Mariusz; Schwartzman, Sergio; Sprabery, Aubrey Trevelin; Gellett, Amanda M; Park, So Young; Bertram, Clinton C; Ogdie, Alexis.
Afiliación
  • Eder L; Department of Medicine, Women's College Hospital, University of Toronto, 76 Grenville St, 6th Floor, Toronto, ON, Canada. Lihi.eder@wchospital.ca.
  • Tony HP; Rheumatology/Clinical Immunology, University Hospital of Würzburg, Würzburg, Germany.
  • Odhav S; Arthritis Clinic, Jackson, TN, USA.
  • Agirregoikoa EG; Rheumatology Department, University Hospital Basurto, Bilbao, Spain.
  • Korkosz M; Jagiellonian University Medical College, Kraków, Poland.
  • Schwartzman S; The Hospital for Special Surgery, New York, NY, USA.
  • Sprabery AT; Eli Lilly and Company, Indianapolis, IN, USA.
  • Gellett AM; Eli Lilly and Company, Indianapolis, IN, USA.
  • Park SY; Eli Lilly and Company, Indianapolis, IN, USA.
  • Bertram CC; Eli Lilly and Company, Indianapolis, IN, USA.
  • Ogdie A; Penn Medicine, Philadelphia, PA, USA.
Rheumatol Ther ; 9(3): 919-933, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35397092
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Rheumatol Ther Año: 2022 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Rheumatol Ther Año: 2022 Tipo del documento: Article País de afiliación: Canadá